Logo image of TCBI

TEXAS CAPITAL BANCSHARES INC (TCBI) Stock Fundamental Analysis

USA - NASDAQ:TCBI - US88224Q1076 - Common Stock

78.89 USD
+1.81 (+2.35%)
Last: 10/17/2025, 8:00:01 PM
78.8 USD
-0.09 (-0.11%)
After Hours: 10/17/2025, 8:00:01 PM
Fundamental Rating

3

TCBI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 391 industry peers in the Banks industry. Both the profitability and financial health of TCBI have multiple concerns. TCBI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

TCBI had positive earnings in the past year.
TCBI had a positive operating cash flow in the past year.
Each year in the past 5 years TCBI has been profitable.
Each year in the past 5 years TCBI had a positive operating cash flow.
TCBI Yearly Net Income VS EBIT VS OCF VS FCFTCBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

The Return On Assets of TCBI (0.37%) is worse than 80.82% of its industry peers.
TCBI's Return On Equity of 3.33% is on the low side compared to the rest of the industry. TCBI is outperformed by 81.59% of its industry peers.
Industry RankSector Rank
ROA 0.37%
ROE 3.33%
ROIC N/A
ROA(3y)0.64%
ROA(5y)0.55%
ROE(3y)5.83%
ROE(5y)5.35%
ROIC(3y)N/A
ROIC(5y)N/A
TCBI Yearly ROA, ROE, ROICTCBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

TCBI has a worse Profit Margin (11.72%) than 79.28% of its industry peers.
In the last couple of years the Profit Margin of TCBI has declined.
The Operating Margin and Gross Margin are not available for TCBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 11.72%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.07%
PM growth 5Y-25.53%
GM growth 3YN/A
GM growth 5YN/A
TCBI Yearly Profit, Operating, Gross MarginsTCBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

TCBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
TCBI has less shares outstanding than it did 1 year ago.
TCBI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TCBI has been reduced compared to a year ago.
TCBI Yearly Shares OutstandingTCBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
TCBI Yearly Total Debt VS Total AssetsTCBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

The Debt to FCF ratio of TCBI is 1.61, which is an excellent value as it means it would take TCBI, only 1.61 years of fcf income to pay off all of its debts.
TCBI has a Debt to FCF ratio of 1.61. This is comparable to the rest of the industry: TCBI outperforms 54.48% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that TCBI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, TCBI is in line with its industry, outperforming 50.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.61
Altman-Z N/A
ROIC/WACCN/A
WACC17.01%
TCBI Yearly LT Debt VS Equity VS FCFTCBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TCBI Yearly Current Assets VS Current LiabilitesTCBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

TCBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.36%, which is quite impressive.
The Earnings Per Share has been decreasing by -7.07% on average over the past years.
The Revenue has decreased by -4.89% in the past year.
TCBI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.75% yearly.
EPS 1Y (TTM)100.36%
EPS 3Y-2.08%
EPS 5Y-7.07%
EPS Q2Q%97.5%
Revenue 1Y (TTM)-4.89%
Revenue growth 3Y0.92%
Revenue growth 5Y-2.75%
Sales Q2Q%15.15%

3.2 Future

Based on estimates for the next years, TCBI will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.71% on average per year.
Based on estimates for the next years, TCBI will show a quite strong growth in Revenue. The Revenue will grow by 12.22% on average per year.
EPS Next Y45.1%
EPS Next 2Y27.77%
EPS Next 3Y18.71%
EPS Next 5YN/A
Revenue Next Year22.48%
Revenue Next 2Y15.72%
Revenue Next 3Y12.22%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TCBI Yearly Revenue VS EstimatesTCBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
TCBI Yearly EPS VS EstimatesTCBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.21, TCBI is valued correctly.
Based on the Price/Earnings ratio, TCBI is valued a bit more expensive than the industry average as 66.50% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.42, TCBI is valued a bit cheaper.
With a Price/Forward Earnings ratio of 11.21, the valuation of TCBI can be described as very reasonable.
Based on the Price/Forward Earnings ratio, TCBI is valued a bit more expensive than the industry average as 62.66% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of TCBI to the average of the S&P500 Index (22.94), we can say TCBI is valued rather cheaply.
Industry RankSector Rank
PE 14.21
Fwd PE 11.21
TCBI Price Earnings VS Forward Price EarningsTCBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.29% of the companies in the same industry are more expensive than TCBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.39
EV/EBITDA N/A
TCBI Per share dataTCBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TCBI's earnings are expected to grow with 18.71% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y27.77%
EPS Next 3Y18.71%

0

5. Dividend

5.1 Amount

TCBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TEXAS CAPITAL BANCSHARES INC

NASDAQ:TCBI (10/17/2025, 8:00:01 PM)

After market: 78.8 -0.09 (-0.11%)

78.89

+1.81 (+2.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-22 2025-10-22/amc
Inst Owners102.42%
Inst Owner Change0.12%
Ins Owners1.72%
Ins Owner Change1.78%
Market Cap3.61B
Analysts69
Price Target94.08 (19.25%)
Short Float %3.76%
Short Ratio3.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.37
Dividend Growth(5Y)13.5%
DP14.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.87%
Min EPS beat(2)-6.76%
Max EPS beat(2)20.5%
EPS beat(4)3
Avg EPS beat(4)28.02%
Min EPS beat(4)-6.76%
Max EPS beat(4)68.72%
EPS beat(8)4
Avg EPS beat(8)4.29%
EPS beat(12)5
Avg EPS beat(12)-3.14%
EPS beat(16)6
Avg EPS beat(16)-4.2%
Revenue beat(2)1
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-3.45%
Max Revenue beat(2)0.76%
Revenue beat(4)1
Avg Revenue beat(4)-14.01%
Min Revenue beat(4)-51.56%
Max Revenue beat(4)0.76%
Revenue beat(8)1
Avg Revenue beat(8)-8.14%
Revenue beat(12)4
Avg Revenue beat(12)1.86%
Revenue beat(16)6
Avg Revenue beat(16)0.94%
PT rev (1m)0.07%
PT rev (3m)15.53%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)7.62%
EPS NY rev (1m)0%
EPS NY rev (3m)9.64%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.67%
Valuation
Industry RankSector Rank
PE 14.21
Fwd PE 11.21
P/S 3.62
P/FCF 9.39
P/OCF 8.7
P/B 1.03
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)5.55
EY7.04%
EPS(NY)7.04
Fwd EY8.92%
FCF(TTM)8.4
FCFY10.65%
OCF(TTM)9.07
OCFY11.5%
SpS21.79
BVpS76.71
TBVpS76.67
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 3.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 11.72%
GM N/A
FCFM 38.56%
ROA(3y)0.64%
ROA(5y)0.55%
ROE(3y)5.83%
ROE(5y)5.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.07%
PM growth 5Y-25.53%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.61
Debt/EBITDA N/A
Cap/Depr 57.58%
Cap/Sales 3.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 329.09%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC17.01%
ROIC/WACCN/A
Cap/Depr(3y)61.66%
Cap/Depr(5y)38.62%
Cap/Sales(3y)3.13%
Cap/Sales(5y)2.02%
Profit Quality(3y)314.03%
Profit Quality(5y)1177.45%
High Growth Momentum
Growth
EPS 1Y (TTM)100.36%
EPS 3Y-2.08%
EPS 5Y-7.07%
EPS Q2Q%97.5%
EPS Next Y45.1%
EPS Next 2Y27.77%
EPS Next 3Y18.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.89%
Revenue growth 3Y0.92%
Revenue growth 5Y-2.75%
Sales Q2Q%15.15%
Revenue Next Year22.48%
Revenue Next 2Y15.72%
Revenue Next 3Y12.22%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y351.26%
FCF growth 3Y-13.94%
FCF growth 5YN/A
OCF growth 1Y350.13%
OCF growth 3Y-9.88%
OCF growth 5YN/A